Show simple item record

dc.contributor.authorCibulskis, Kristian
dc.contributor.authorSivachenko, Andrey
dc.contributor.authorJaffe, David B.
dc.contributor.authorSougnez, Carrie
dc.contributor.authorGabriel, Stacey B.
dc.contributor.authorMeyerson, Matthew L.
dc.contributor.authorGetz, Gad
dc.contributor.authorLawrence, Michael S.
dc.contributor.authorCarter, Scott L.
dc.contributor.authorLander, Eric Steven
dc.date.accessioned2014-02-07T16:00:47Z
dc.date.available2014-02-07T16:00:47Z
dc.date.issued2013-02
dc.date.submitted2012-09
dc.identifier.issn1087-0156
dc.identifier.issn1546-1696
dc.identifier.urihttp://hdl.handle.net/1721.1/84673
dc.description.abstractDetection of somatic point substitutions is a key step in characterizing the cancer genome. However, existing methods typically miss low-allelic-fraction mutations that occur in only a subset of the sequenced cells owing to either tumor heterogeneity or contamination by normal cells. Here we present MuTect, a method that applies a Bayesian classifier to detect somatic mutations with very low allele fractions, requiring only a few supporting reads, followed by carefully tuned filters that ensure high specificity. We also describe benchmarking approaches that use real, rather than simulated, sequencing data to evaluate the sensitivity and specificity as a function of sequencing depth, base quality and allelic fraction. Compared with other methods, MuTect has higher sensitivity with similar specificity, especially for mutations with allelic fractions as low as 0.1 and below, making MuTect particularly useful for studying cancer subclones and their evolution in standard exome and genome sequencing data.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant U54HG003067)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant U24CA143845)en_US
dc.language.isoen_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/nbt.2514en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePMCen_US
dc.titleSensitive detection of somatic point mutations in impure and heterogeneous cancer samplesen_US
dc.typeArticleen_US
dc.identifier.citationCibulskis, Kristian, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, and Gad Getz. “Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.” Nature Biotechnology 31, no. 3 (February 10, 2013): 213-219.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.mitauthorLander, Eric S.en_US
dc.relation.journalNature Biotechnologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsCibulskis, Kristian; Lawrence, Michael S; Carter, Scott L; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S; Getz, Gaden_US
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record